SBS Operating Expenses

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) · Operating Expenses

SBS logo

SBS Operating Expenses

Latest reportedR$1.73B BRL
SBS TTM Operating Expenses · BRL (R$475.62M → R$1.73B)
High-resolution chart · PNG

SBS operating expenses history

Trailing twelve months (TTM) · BRL. Each value covers four complete reported quarters.

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) Operating Expenses — Trailing twelve months (TTM) (BRL)
Period endingOperating Expenses (BRL)
1,725,249,868
1,433,590,658
1,645,938,000
2,470,392,000
3,216,637,000
3,469,507,000
3,715,609,000
9,969,232,001
9,609,278,001
9,832,000,001
9,560,587,001
-282,362,000
-402,173,000
-491,065,000
-533,348,000
-282,895,999
-378,008,999
-584,442,999
-667,745,000
-874,675,001
-964,511,001
-1,067,904,001
-985,528,000
-2,252,874,000
-2,273,519,000
-2,155,218,000
-2,361,851,000
2,037,284,000
1,934,320,000
1,749,359,000
1,823,109,000
1,861,306,000
1,833,377,000
1,879,305,000
1,873,362,000
1,527,509,000
1,629,728,000
1,467,016,000
1,458,621,000
1,598,951,000
1,393,666,000
1,287,216,000
401,111,000
559,070,000
636,883,000
884,578,000
1,664,455,000
1,509,937,000
1,475,389,000
1,346,397,000
1,362,924,000
1,389,005,000
1,502,171,000
1,449,263,000
1,450,422,000
1,393,662,000
1,306,498,000
1,324,806,000
1,450,314,000
1,493,398,000
1,466,586,000
1,518,756,000
1,364,241,000
1,698,184,000
1,709,695,000
1,391,808,000
1,372,139,000
2,084,575,000
2,137,603,000
2,423,143,000
2,512,017,000
1,253,115,280
1,275,946,160
1,254,548,862
1,193,474,662
1,059,956,921
1,118,388,444
1,164,240,158
1,100,823,731
1,485,759,766
1,389,741,826
1,169,366,826
1,241,847,491
570,756,286
387,751,514
811,869,955
815,954,842
932,151,231
1,258,316,430
702,367,139
549,988,230
-1,425,109,668
-444,021,138
521,751,109
475,623,177
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.